Inhibitor Therapeutics, Inc. (INTI) › Total LiabilitiesInhibitor Therapeutics, Inc. (INTI) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2012: $1.07M2013: $776.1K2014: $400.9K2015: $461.9K2016: $308.1K2017: $601.5K2018: $1.20M2019: $3.43M2020: $3.49M2021: $3.68M2022: $3.68M2023: $3.67M2024: $3.71M2025: $3.80M$3.80M2012Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$3.80M+2.5%2024$3.71M+1.2%2023$3.67M-0.4%2022$3.68M-0.0%2021$3.68M+5.4%2020$3.49M+1.8%2019$3.43M+185.8%2018$1.20M+99.6%2017$601.5K+95.2%2016$308.1K-33.3%2015$461.9K+15.2%2014$400.9K-48.3%2013$776.1K-27.4%2012$1.07M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share